APPLICATION OF ANALYTICAL HIERARCHY PROCESS FOR COMPARING VORTIOXETINE TO AGOMELATINE AND VENLAFAXINE XR IN MAJOR DEPRESSIVE DISORDER

被引：0
|
作者：
Briquet, B. [1 ]
Diamand, F. [2 ]
Francois, C. [3 ]
Brignone, M. [4 ]
机构：
[1] Benjamin BRIQUET, Levoncourt, France
[2] Lundbeck SAS, Paris, France
[3] Lundbeck, Deerfield, IL USA
[4] Lundbeck SAS, Issy Les Moulineaux, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH8
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [21] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
    van Baardewijk, M
    Vis, PMJ
    Einarson, TR
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1271 - 1279
  • [22] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
    Van Baardewijk, M
    Vis, PM
    Einarson, T
    VALUE IN HEALTH, 2005, 8 (06) : A209 - A210
  • [23] Vortioxetine for the treatment of major depressive disorder
    Tritschler, Laurent
    Felice, Daniela
    Colle, Romain
    Guilloux, Jean-Philippe
    Corruble, Emmanuelle
    Gardier, Alain Michel
    David, Denis Joseph
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 731 - 745
  • [24] Vortioxetine in the treatment of major depressive disorder
    Baldwin, David S.
    Hanumanthaiah, Venkatesh Ballagere
    FUTURE NEUROLOGY, 2015, 10 (02) : 79 - 89
  • [25] Agomelatine Treatment of Major Depressive Disorder
    Dolder, Christian R.
    Nelson, Michael
    Snider, Morgan
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) : 1822 - 1831
  • [26] Venlafaxine XR versus fluoxetine in the treatment of major depressive disorder and generalized anxiety disorder dual diagnosis
    Vasile, D.
    Vasiliu, O.
    Ivanov, P.
    Ojog, D.
    Sarmache, M.
    Vasile, M.
    EUROPEAN PSYCHIATRY, 2007, 22 : S247 - S247
  • [27] Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder
    Nierenberg, Andrew A.
    Trivedi, Madhukar H.
    Gaynes, Bradley N.
    Mitchell, Jeff
    Davis, Lori L.
    Husain, Mustafa M.
    Wisniewski, Stephen R.
    Fava, Maurizio
    Warden, Diane
    Luther, James F.
    van Nieuwenhuizen, Adrienne O.
    Morris, David W.
    Shelton, Richard C.
    Rush, A. John
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 (10): : 956 - 967
  • [28] Venlafaxine XR Does Not Alter Biomarkers of Bone Turnover in Older Adults With Major Depressive Disorder
    Shea, Marcie L.
    Garfield, Lauren D.
    Mulsant, Benoit H.
    Reynolds, Charles
    Civitelli, Roberto
    Teitelbaum, Steven
    Lenze, Eric J.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 20 (03): : S97 - S97
  • [29] Randomised, double-blind study of vortioxetine versus venlafaxine in adults with major depressive disorder (MDD)
    Wang, G.
    Gislum, M.
    Filippov, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 142 - 142
  • [30] A randomized, double-blind study comparing the efficacy and safety of trazodone oad and venlafaxine XR for the treatment of patients with major depressive disorder
    Salvatori, E.
    Comandini, A.
    Di Loreto, G.
    Olivieri, L.
    Tongiani, S.
    Albert, U.
    Fagiolini, A.
    Kasper, S.
    EUROPEAN PSYCHIATRY, 2019, 56 : S90 - S90
12345